Acceptance and commitment therapy for breast cancer survivors with fear of cancer recurrence: A 3-arm pilot randomized controlled trial.
Open accessAbstract
Background: Fear of cancer recurrence (FCR) has a profound negative impact on quality of life (QOL) for many cancer survivors. Breast cancer survivors (BCS) are particularly vulnerable, with up to 70% reporting clinically significant FCR. To the authors' knowledge, evidence-based interventions for managing FCR are limited. Acceptance and commitment therapy (ACT) promotes psychological flexibility in managing life's stressors. The current study examined the feasibility and preliminary efficacy of group-based ACT for FCR in BCS.Methods: Post-treatment BCS (91 patients with stage I-III disease) with clinical FCR randomly were assigned to ACT (6 weekly 2-hour group sessions), survivorship education (SE; 6 weekly 2-hour group sessions), or enhanced usual care (EUC; one 30-minute group coaching session with survivorship readings). FCR severity (primary outcome) and avoidant coping, anxiety, post-traumatic stress, depression, QOL, and other FCR-related variables (secondary outcomes) were assessed at baseline (T1), after the intervention (T2), 1 month after the intervention (T3), and 6 months after the intervention (T4) using intent-to-treat analysis.Results: Satisfactory recruitment (43.8%) and retention (94.5%) rates demonstrated feasibility. Although each arm demonstrated within-group reductions in FCR severity over time, only ACT produced significant reductions at each time point compared with baseline, with between-group differences at T4 substantially favoring ACT over SE (Cohen d for effect sizes, 0.80; P < .001) and EUC (Cohen d, 0.61; P < .01). For 10 of 12 secondary outcomes, only ACT produced significant within-group reductions across all time points. By T4, significant moderate to large between-group comparisons favored ACT over SE and EUC with regard to avoidant coping, anxiety, depression, QOL, and FCR-related psychological distress.Conclusions: Group-based ACT is a feasible and promising treatment for FCR and associated outcomes in BCS that warrants testing in larger, fully powered trials.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
1 of 20 cited sources checked · 0 supported · 0 flagged · accuracy not yet measured
- Interpretationcitation
The physical and mental QoL gains reported by ACT participants probably stemmed from both lower anxiety and greater psychological flexibility.
“This interpretation is supported by ACT participants’ reported physical and mental QoL improvement, which likely resulted from a combination of reduced anxiety and increased psychological flexibility.23–26”
Quote in the paperNot a substantial claim1 of 4 sources checked- cites [23]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [24] source
- cites [25] source
- cites [26] source
The Quality of life (QoL) section (page unavailable) reports that most reviewed studies found QoL improvements after ACT, while the Psychological flexibility section reports post-ACT gains in flexibility. The Distress section also describes improvements in distress, including post-stroke anxiety. The review does not establish that reduced anxiety and increased flexibility jointly caused physical and mental QoL gains, and it cautions that other factors may explain post-intervention QoL improvements. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Findingown data
All three arms had within-group decreases in FCR severity across time.
“Although each arm showed within-group FCR severity reductions over time”
- Also stated in: § Primary Outcome · plain
“Each group showed within-group reductions in FCR severity by T4”
Quote in the paperNot a substantial claim - Also stated in: § Primary Outcome · plain
- Findingown data
At T2, ACT showed significantly larger FCR severity reductions than SE with a moderate effect (d=0.68, p<0.05).
“compared to SE, ACT showed significantly larger FCR severity reductions with a moderate effect at T2 (d=0.68, p<0.05)”
Quote in the paperSubstantial claim - Findingreasoning
ACT's efficacy increased with longer follow-up.
“As more time passed, ACT became more efficacious.”
Quote in the paperSubstantial claim - Findingown data
No differences between SE and EUC were observed on FCR severity.
“No differences between SE and EUC on FCR severity were observed.”
Quote in the paperNot a substantial claim
- Findingreasoning
ACT's impact was greatest at T4.
“This may explain why ACT’s impact was greatest at T4.”
Quote in the paperSubstantial claim - Findingown data
SE and EUC did not differ on secondary outcomes.
“No differences between SE and EUC were observed on secondary outcomes.”
Quote in the paperNot a substantial claim - Findingown data
Only a minority of secondary outcomes showed significant within-group improvement for SE and EUC participants.
“Conversely, SE and EUC participants reported significant within-group improvements on only a fraction of secondary outcomes.”
Quote in the paperSubstantial claim - Findingown data
ACT participants had significant within-group gains on every secondary outcome except FCRI-Reassurance Seeking and FCRI-Coping Strategies at all assessments.
“At each time point, ACT participants reported significant within-group improvements on all secondary outcomes except FCRI-Reassurance Seeking and FCRI-Coping Strategies (Table 2).”
Quote in the paperSubstantial claim - Findingown data
Only ACT showed significant FCR severity improvement at every assessment compared with baseline.
“only ACT produced significant reductions at each time point relative to baseline”
- Also stated in: § Primary Outcome · plain
“only ACT produced significant improvement at each time point”
Quote in the paperSubstantial claim - Also stated in: § Primary Outcome · plain
- Findingown data
At T4, ACT was superior to SE on FCR severity with a large effect (d=0.80, p<0.001).
“between-group differences at T4 substantially favoring ACT over SE (d=0.80, p<0.001)”
- Also stated in: § Primary Outcome · plain
“large effect by T4 (d=0.80, p<0.001)”
Quote in the paperSubstantial claim - Also stated in: § Primary Outcome · plain
- Findingown data
At T4, ACT was superior to EUC on FCR severity with a moderate effect (d=0.61, p<0.01).
“and EUC (d=0.61, p<0.01)”
- Also stated in: § Primary Outcome · plain
“At T4, ACT became superior to EUC on FCR severity (d=0.61, p<0.01).”
Quote in the paperSubstantial claim - Also stated in: § Primary Outcome · plain
- Findingown data
Significant differences were absent for just two FCRI subscales: Reassurance Seeking and Coping Strategies.
“Only two FCRI subscales (i.e., Reassurance Seeking, Coping Strategies) failed to show significant differences”
Quote in the paperNot a substantial claim - Findingown data
By T4, most secondary outcomes showed moderate-to-large improvements that favored ACT.
“Moderate-to-large improvements on most secondary outcomes were also observed favoring ACT by T4.”
Quote in the paperSubstantial claim - Findingown data
Only ACT yielded significant within-group decreases on 10 of 12 secondary outcomes at every time point.
“For 10 of 12 secondary outcomes, only ACT produced significant within-group reductions across all time points.”
Quote in the paperSubstantial claim - Findingreasoning
Compared with ACT, SE and EUC had relatively small decreases in FCR severity and secondary outcomes.
“Both SE and EUC groups showed relatively weak reductions in FCR severity and secondary outcomes compared to ACT.”
Quote in the paperSubstantial claim - Interpretationreasoning
Lessening avoidant coping could be central to managing FCR and related problems over the survivorship period.
“Reducing avoidant coping in particular may be pivotal in managing FCR and its correlates throughout survivorship.”
Quote in the paperSubstantial claim - Premisecitation
FCR negatively affects quality of life for many cancer survivors.
“Left untreated, debilitating fears may linger throughout survivorship1,2 reducing quality of life (QoL).1,2,8,11,12”
- Also stated in: § Background: · plain
“Fear of cancer recurrence (FCR) has a profound negative impact on many cancer survivors’ quality of life (QoL).”
Quote in the paperSubstantial claim0 of 5 sources checked - Also stated in: § Background: · plain
- Interpretationown data
Group-based ACT is promising for FCR and associated outcomes in BCS.
“Group-based ACT is a feasible and promising treatment for FCR and associated outcomes in BCS that warrants testing in larger, fully-powered trials.”
- Also stated in: § DISCUSSION · hedged
“our results suggest ACT is a promising treatment for reducing FCR in BCS.”
Quote in the paperSubstantial claim - Also stated in: § DISCUSSION · hedged
- Interpretationown data
Group-based ACT is feasible for FCR in BCS.
“Group-based ACT is a feasible and promising treatment for FCR and associated outcomes in BCS that warrants testing in larger, fully-powered trials.”
Quote in the paperSubstantial claim- Rests on an assumption: The observed recruitment (43.8%) and retention (94.5%) rates are satisfactory for demonstrating feasibility.
- Premisecitation
ACT enhances psychological flexibility when coping with stressors.
“Acceptance and Commitment Therapy (ACT) promotes psychological flexibility in managing life’s stressors.”
- Also stated in: § INTRODUCTION · plain
“Acceptance and Commitment Therapy (ACT) is designed to maximize psychological flexibility in navigating life’s challenges22”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [22]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Also stated in: § INTRODUCTION · plain
- Premisecitation
Less avoidant coping is thought to enhance psychological flexibility, enabling more adaptive responses to cancer and other difficulties.
“Theoretically, reducing avoidant coping promotes psychological flexibility, allowing individuals to pursue more adaptive strategies to handle cancer-related and other challenges.43”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [43] source
- Interpretationreasoning
Addressing FCR alongside maladaptive coping might also lead to parallel decreases in distress.
“Second, it appears targeting FCR while reducing maladaptive coping may promote concomitant reductions in distress outcomes.”
Quote in the paperSubstantial claim - Interpretationreasoning
Information by itself does not sufficiently reduce the burden of FCR.
“Taken together, our findings suggest that providing information alone is inadequate in lessening FCR’s impact.”
Quote in the paperSubstantial claim - Interpretationown data
ACT shows promise for lowering FCR among breast cancer survivors.
“our results suggest ACT is a promising treatment for reducing FCR in BCS.”
Quote in the paperSubstantial claim - Study design and conductown data
Validated self-report instruments with Cronbach's alphas of 0.64 to 0.91 measured the primary and secondary outcomes.
“Primary and secondary outcomes were assessed using valid, reliable self-report measures with Cronbach’s alphas ranging from 0.64–0.91.”
Quote in the paperSubstantial claim - Study design and conductown data
Groups were comparable on demographic and clinical variables except for cancer treatments received.
“Except for cancer treatments received, groups were similar on demographic and clinical characteristics.”
Quote in the paperNot a substantial claim - Study design and conductnone given
The pilot had at least 80% power for pairwise differences on continuous outcomes when each arm had 26 or more participants.
“With ≥26 per arm, this pilot had ≥80% power to detect pairwise group differences on continuous outcomes with a GLM-based t-test.”
Quote in the paperNot a substantial claim - Interpretationown data
Compelling evidence of preliminary efficacy was obtained.
“Compelling evidence of preliminary efficacy was also obtained.”
Quote in the paperSubstantial claim - Study design and conductreasoning
The study did not fully measure other coping styles, such as hypervigilance, that could drive recurrence anxiety.
“thus, other coping styles (e.g., hypervigilance) that may fuel recurrence anxiety were not comprehensively assessed.”
Quote in the paperNot a substantial claim
- May combine two claims. 24
- The quote only partly states this claim. 1
- Classified as probably not a substantial claim. 12
May combine two claims.
Findingown dataAt T4, ACT outperformed EUC on 7 of the 12 secondary outcomes, with moderate to large effects.
“and superior to EUC on 7 of 12 outcomes with moderate to large effect sizes”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAt every time point, between-group comparisons favored ACT, especially at T4.
“Between-group differences at each time point favored ACT, most obviously at T4”
Quote in the paperSubstantial claimMay combine two claims. The quote only partly states this claim.
Findingown dataAt T4, ACT outperformed SE on 10 of the 12 secondary outcomes, with moderate to large effects.
“by T4 ACT was superior to SE on 10 of 12 secondary outcomes”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataFeasibility was supported by accrual of 43.8% among screened and 60.7% among eligible women, attendance of 81.7%, and retention of 94.5%.
“ACT showed strong evidence of feasibility with high accrual (43.8% of BCS screened; 60.7% of eligible BCS), attendance (81.7%), and retention (94.5%) rates.”
Quote in the paperSubstantial claim- Rests on an assumption: The observed recruitment (43.8%) and retention (94.5%) rates are satisfactory for demonstrating feasibility.
May combine two claims.
Findingown dataBy T4, ACT was superior to SE and EUC on avoidant coping, anxiety, depression, QoL, and FCR-related psychological distress with moderate-to-large effects.
“By T4, significant moderate-to-large between-group comparisons favored ACT over SE and EUC on avoidant coping, anxiety, depression, QoL, and FCR-related psychological distress.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCompared with baseline, ACT had significant within-group gains on FCR severity and almost all secondary outcomes at every follow-up, while SE and EUC changed little.
“Relative to baseline, ACT showed significant within-group improvement on FCR severity and nearly all secondary outcomes at all follow-ups, whereas SE and EUC showed minimal change across outcomes.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe trial demonstrated satisfactory recruitment (43.8%) and retention (94.5%).
“Satisfactory recruitment (43.8%) and retention (94.5%) demonstrated feasibility.”
- Also stated in: § Feasibility · plain
“Of 208 BCS assessed for eligibility, 91 (43.8%) enrolled and 117 were excluded (Figure 1). Retention was excellent (94.5%) and 89.0% of participants completed all four assessments.”
Quote in the paperSubstantial claim- Rests on an assumption: The observed recruitment (43.8%) and retention (94.5%) rates are satisfactory for demonstrating feasibility.
- Also stated in: § Feasibility · plain
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataThe sample was predominantly White (84%), college-educated (65%), and earning at least $50,000 per year (73%).
“Most participants were White (84%) college graduates (65%) earning ≥$50,000 annually (73%).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAmong 208 breast cancer survivors screened, 91 (43.8%) enrolled and 117 were excluded.
“Of 208 BCS assessed for eligibility, 91 (43.8%) enrolled and 117 were excluded (Figure 1).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAttendance was comparable for ACT (81.7%) and SE (86.7%; p=0.47), and all EUC participants attended the one coaching session.
“Attendance rates were similar across ACT (81.7%) and SE (86.7%; p=0.47) with 100% of EUC participants attending the single coaching session.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe retention rate was 94.5%, and 89.0% finished all four assessments.
“Retention was excellent (94.5%) and 89.0% of participants completed all four assessments.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationAvoidance may briefly relieve cancer-related anxiety, yet rebound effects can keep FCR elevated over time.
“While avoidant coping allows survivors to escape anxiety-provoking thoughts about cancer in the short-term, rebound-effects produce sustained, elevated levels of FCR over time.42”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [42] source
May combine two claims.
InterpretationcitationAt six months post-intervention, ACT yielded larger FCR severity reductions than both SE and EUC, and the differences reached clinical significance.
“six months after intervention, ACT participants reported greater reductions in FCR severity relative to both SE and EUC with differences large enough to be considered clinically significant.40”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [40] source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationBreast cancer survivors are especially vulnerable to clinically significant FCR, with up to 70% reporting it.
“Breast cancer survivors (BCS) are particularly vulnerable with up to 70% reporting clinically-significant FCR.”
- Also stated in: § INTRODUCTION · plain
“up to 70% of survivors report clinically-significant FCR,8,9 making it the most frequently-reported unmet need of BCS.1,10”
Quote in the paperNot a substantial claim0 of 4 sources checked- Also stated in: § INTRODUCTION · plain
May combine two claims.
InterpretationcitationGroup delivery of ACT appears efficacious and may lower costs and reach more people than individual delivery.
“First, ACT can be delivered efficaciously to a group, potentially reducing costs and increasing the number of those served over individually-delivered interventions.27,29”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [27]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [29] source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductreasoningWhile the Cancer-AAQ assessed avoidant coping, the FCRI-Coping Strategies subscale mainly counts strategies and reveals little about specific coping styles.
“Although the Cancer-AAQ captured avoidant coping, the FCRI-Coping Strategies subscale is essentially a count measure of adaptive and maladaptive coping strategies and provided little insight into specific coping styles”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductreasoningAs a pilot, the study lacked full power for efficacy, so a larger randomized trial is needed to confirm the findings.
“Second, this pilot was not a fully-powered efficacy trial, necessitating a larger randomized trial to confirm results.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe sample was mostly White, wealthy, and college-educated, so findings may not generalize to other groups.
“A limitation of this study was the largely White, affluent, college-educated sample, limiting generalizability to other groups.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataAllocation was masked from participants and research assistants, and participants did not know the study hypotheses.
“Participants and research assistants were blinded to allocation sequence, and participants were blinded to study hypotheses.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductown dataA general linear model tested between-group differences while controlling for age, cancer stage, education, and treatments received.
“Between-group differences on change scores of the outcomes were tested using a General Linear Model (GLM) while adjusting for theoretically-important covariates (i.e., age, stage of cancer, education)39 and cancer treatments received, which differed significantly between arms at baseline.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [39] source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe study was registered with ClinicalTrials.gov.
“This study is registered with ClinicalTrials.gov ().”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningA 6-month follow-up is less rigorous than 12- or 24-month assessments for long-term effects.
“While intended to assess long-term effects of treatment, the pilot’s 6-month follow-up is only modestly rigorous compared to a 12- or 24-month follow-up assessment”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAn intent-to-treat approach analyzed all available data, irrespective of attendance or adherence.
“Using an intent-to-treat design, all available data were analyzed regardless of participants’ attendance or adherence.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataA biostatistician created the allocation sequence using randomly varied blocks, and it was hidden in opaque, sequentially numbered envelopes.
“The allocation sequence was generated by the biostatistician in randomly-varied block sizes of three or six and concealed in opaque sequentially-numbered envelopes.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataNormality and equal variances were met, as checked with histograms and scatterplots.
“Assumptions of normality and homogeneity of variances were satisfied and assessed with histograms and scatterplots.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataFidelity averaged 95.6% in ACT and 93.8% in SE.
“Average fidelity ratings were 95.6% for ACT and 93.8% for SE.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningACT, but not SE or EUC, might lower maladaptive avoidance and thus help manage FCR and related distress over time.
“Unlike SE or EUC, ACT may reduce maladaptive avoidant coping, thereby contributing to long-term management of FCR and associated distress.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe Indiana University IRB approved study procedures.
“The Indiana University Institutional Review Board (#1507511085) approved study procedures.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningSE and EUC provided indirect FCR resources but did not directly teach coping with fearful thoughts and emotions, which might be crucial for comorbid distress and FCR.
“Both offered resources to indirectly manage FCR but did not directly promote adaptive coping with fearful thoughts and emotions, which may be key in addressing comorbid distress and FCR.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataPairwise arm comparisons used Tukey-Kramer tests with family-wise alpha set at 0.05 per outcome.
“Post-hoc Tukey-Kramer tests assessed pairwise differences between arms while controlling the family-wise alpha at 0.05 for each outcome.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
The observed recruitment (43.8%) and retention (94.5%) rates are satisfactory for demonstrating feasibility.
“Satisfactory recruitment (43.8%) and retention (94.5%) demonstrated feasibility.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The average fidelity rating across all rated TACTICs sessions was 98.6% (SD = 0.03), indicating high adherence to the intervention manual.
“The average fidelity rating across all sessions rated was 98.6% (SD = 0.03), suggesting the interventionist delivered TACTICs in a manner that was highly adherent to the intervention manual.”
From Feasibility and acceptability of an acceptance and commitment therapy intervention for caregivers of adults with Alzheimer’s disease and related dementias (2021) · cites this paper as [36]
The Methods > Interventions > Treatment Fidelity passage reports average fidelity ratings of 95.6% for ACT and 93.8% for survivorship education, not 98.6%. It does not identify an intervention called TACTICs or report an SD of 0.03. No page number is available in our copy. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredStrong evidence of feasibility and acceptability was reported, with high accrual and retention or enrollment rates and high satisfaction with the sessions.
“Strong evidence of feasibility and acceptability was reported, with high accrual and retention or enrollment rates [44, 45], high ratings for essentialness and effectiveness of the intervention [47], moderate to high ratings for usefulness or expected benefits from the intervention [48, 52, 54], and high degree of satisfaction with the sessions [45, 46, 48, 51] (see Table 4 for details).”
From Acceptance and commitment therapy in adult cancer survivors: a systematic review and conceptual model (2021) · cites this paper as [44]
The Discussion reports strong evidence of feasibility, citing high accrual and retention, and Results > Feasibility gives the corresponding rates. Our copy does not report participant satisfaction with the sessions, so that part of the attributed claim is unsupported. (LLM, conf=0.86)
Experimental — accuracy not yet measuredIn a 3-arm pilot randomized controlled trial addressing fear of cancer recurrence among breast cancer survivors, Acceptance and Commitment Therapy demonstrated greater acceptability and improvements in mental and physical quality of life, cognitive flexibility, and a reduction in avoidant coping skills, relative to survivorship education and enhanced usual care.
“in a 3-arm pilot RCT addressing fear of cancer recurrence among breast cancer survivors, ACT demonstrated greater acceptability and improvements in mental and physical quality of life, cognitive flexibility, and a reduction in avoidant coping skills, relative to survivorship education and enhanced usual care [43].”
From A digital, coach-assisted intervention to address the psychosocial needs of young adult cancer survivors: Randomized controlled trial protocol and intervention adaptation process (2024) · cites this paper as [43]
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredThe 13 reviewed articles were published between 2015 and 2019 and came from studies conducted in the USA, Australia, Spain, and Iran.
“The 13 articles selected for review were published between 2015 and 2019 from studies conducted in USA [44–46], Australia [47–52], Spain [53, 54], and Iran [55].”
From Acceptance and commitment therapy in adult cancer survivors: a systematic review and conceptual model (2021) · cites this paper as [44]
The Methods > Procedures passage identifies this as a study of breast cancer survivors receiving care at clinics in Indiana, supporting its inclusion among the USA studies. Our copy does not establish the claimed 2015–2019 publication window or the review’s total of 13 articles; this individual trial cannot substantiate the studies attributed to Australia, Spain, and Iran. (LLM, conf=0.81)
Experimental — accuracy not yet measuredEight studies reported time since cancer diagnosis; the average time post-diagnosis was 36.45 months, with a range of 27 to 64.08 months.
“Eight studies reported time since cancer diagnosis for the participants; the average time post-diagnosis was 36.45 months, with a range of 27 months [47] to 64.08 months [44].”
From Acceptance and commitment therapy in adult cancer survivors: a systematic review and conceptual model (2021) · cites this paper as [44]
The Results, under Participant Characteristics (page unavailable), report a mean time since diagnosis of approximately 64 months for this trial, consistent with the upper end attributed to [44]. Our copy does not substantiate the more precise figure of 64.08 months. The eight-study average is the citing authors’ summary, not a finding attributed to this individual trial. (LLM, conf=0.82)
Experimental — accuracy not yet measured
About 55% of studies administered the intervention in groups, with each group having 4 to 15 participants.
“The intervention was administered in groups in about 55% of the studies, with each group consisting of 4–15 participants [44–46, 53, 55] (unpublished thesis).”
From Acceptance and commitment therapy in adult cancer survivors: a systematic review and conceptual model (2021) · cites this paper as [44]
The Methods (Interventions and Procedures; page unavailable) describe group-based delivery and report 10–12 participants per ACT or survivorship-education cohort, within the stated 4–15 range. This single trial does not establish that about 55% of studies used groups or that the full range across studies was 4–15. (LLM, conf=0.85)
Experimental — accuracy not yet measuredACT protocols almost always involved exercises, metaphors, and experiential strategies, and acceptance, mindfulness-based, or experiential exercises were used in about 82% of included studies.
“The ACT protocols almost always involved exercises, metaphors, and experiential strategies; acceptance or mindfulness based or experiential exercises were used in about 82% of the included studies [44–48, 51–54].”
From Acceptance and commitment therapy in adult cancer survivors: a systematic review and conceptual model (2021) · cites this paper as [44]
The Methods > Interventions passage describes acceptance, mindfulness, and experiential exercises in this trial’s ACT intervention (page not provided). It does not establish that ACT protocols almost always use these strategies, mention metaphors, or report their use in about 82% of included studies. (LLM, conf=0.88)
Experimental — accuracy not yet measuredAll TACTICs sessions were audio-recorded and assessed for fidelity and ACT skill level using a standardized fidelity checklist adopted from previous ACT pilots.
“Additionally, all TACTICs sessions were audio-recorded and assessed for fidelity and ACT skill level using a standardized fidelity checklist adopted from our previous ACT pilots (Fowler et al., 2021; Johns et al., 2020).”
From Feasibility and acceptability of a telephone-based ACT intervention for caregivers (TACTICs) of adults with Alzheimer's disease and related dementias (ADRD): a randomized pilot during the COVID-19 pandemic. (2025) · cites this paper as Johns et al., 2020
The Methods (Interventions, Treatment Fidelity; page unavailable) report that fidelity checklists were developed for ACT and survivorship-education sessions and that external experts rated 50% of sessions. The paper does not say that all sessions were audio-recorded, that ACT skill level was assessed, or that TACTICs sessions used its checklist. (LLM, conf=0.87)
Experimental — accuracy not yet measuredThe sample size was calculated based on a study in 2020 to achieve a 2.31 two-group mean difference with a 3.650 standard deviation using the formula for mean comparison between two groups.
“The sample size was calculated based on a study in 2020 22 to achieve 2.31 two groups' mean difference with a 3.650 standard deviation with the formula of mean comparison between two groups.”
From A randomized clinical trial: Efficacy of group-based acceptance and commitment therapy program for breast cancer patients with high fear of progression (2024) · cites this paper as [22]
The Methods—Statistical Analysis section describes power for pairwise group comparisons and use of a pooled standard deviation. It does not report a 2.31 two-group mean difference or a 3.650 standard deviation, so our copy does not substantiate the specific values used in the citing paper’s sample-size calculation (no page number available). (LLM, conf=0.78)
Experimental — accuracy not yet measuredAddressing FOP while increasing cognitive defusion may provide more opportunity for cancer patients to put their energy and time on their values and have outcome improvements at T3.
“addressing FOP while increasing cognitive defusion may provide more opportunity for cancer patients to put their energy and time on their values and have outcome improvements at T 3 .22”
From A randomized clinical trial: Efficacy of group-based acceptance and commitment therapy program for breast cancer patients with high fear of progression (2024) · cites this paper as [22]
The Methods > Interventions section says ACT included cognitive defusion and supported breast cancer survivors in aligning behavior with personal values. The Results > Primary Outcome and Secondary Outcomes sections report improvements at T3, one month after treatment. But the study addressed fear of cancer recurrence in breast cancer survivors, not fear of progression (FOP) in cancer patients generally, and it did not establish that increased cognitive defusion led to more time spent on valued activities or caused the T3 improvements. Page numbers are unavailable in our copy. (LLM, conf=0.85)
Experimental — accuracy not yet measuredThere are studies confirming the efficacy of ACT on anxiety and FCR reduction in cancer patients.
“There are some studies confirmed the efficacy of ACT on anxiety and FCR reduction in cancer patients.22,29,38”
From A randomized clinical trial: Efficacy of group-based acceptance and commitment therapy program for breast cancer patients with high fear of progression (2024) · cites this paper as [22]
The Results report greater reductions in fear of cancer recurrence and anxiety with ACT than with the comparison groups. However, the Discussion calls these findings preliminary: this was a pilot study of breast cancer survivors, not a fully powered efficacy trial establishing efficacy across cancer patients generally. (LLM, conf=0.88)
Experimental — accuracy not yet measuredIn the long term, patients with high experiential avoidance find themselves far away from their values, which can decrease their QOL.
“in the long term, patients with high experiential avoidance find themselves far away from their values, which can decrease their QOL.22,[34][35][36]”
From A randomized clinical trial: Efficacy of group-based acceptance and commitment therapy program for breast cancer patients with high fear of progression (2024) · cites this paper as [22]
The Discussion (page unavailable) says avoidant coping may sustain fear of recurrence over time and links reduced avoidance and greater psychological flexibility to improved quality of life. The Methods > Interventions section says ACT supports behavior aligned with personal values. The paper does not establish that patients with high experiential avoidance become distant from their values, or that this distance decreases their quality of life. (LLM, conf=0.82)
Experimental — accuracy not yet measuredACT is effective in managing fear of cancer recurrence and associated significant improvements in avoidant coping, anxiety, depression, and QoL.
“ACT is also effective in managing fear of cancer recurrence and associated significant improvements in avoidant coping, anxiety, depression, and QoL [25].”
From Effectiveness of Acceptance and Commitment Therapy (ACT) on disease acceptance for breast cancer patients: Study protocol of a randomized controlled trial (2024) · cites this paper as [25]
The Results (Primary Outcome and Secondary Outcomes) report significantly greater reductions in fear of cancer recurrence and improvements in avoidant coping, anxiety, depression, and quality of life for ACT participants by the six-month follow-up. However, the Discussion calls this evidence of preliminary efficacy in breast cancer survivors and says the pilot was not a fully powered efficacy trial, so the unqualified statement that ACT is effective overstates the finding. (LLM, conf=0.86)
Experimental — accuracy not yet measuredAn 8-week ACT therapy course decreased stress and other psychological health indices in people with IBD in a randomized controlled experiment.
“An 8-week ACT therapy course decreased stress and other psychological health indices in people with IBD in a randomized controlled experiment.”
From The Effect of Acceptance and Commitment Therapy on Psychological Nursing of Acute Cerebral Infarction with Insomnia, Anxiety, and Depression (2022) · cites this paper as [8]
The Methods (Interventions) describe six weekly ACT sessions for breast cancer survivors, not an eight-week course for people with IBD. The Results (Secondary Outcomes) report improvements in psychological outcomes in this pilot randomized trial, supporting that part of the claim but not its population or duration. (LLM, conf=0.89)
Experimental — accuracy not yet measuredPsychological flexibility can provide significant potential for pattern change in the face of cancer-related problems and discomfort for patients with cancer and survivors.
“When facing life challenges, psychological flexibility can provide a significant potential for pattern change in the face of cancer-related problems and discomfort for patients with cancer and survivors.”
From Acceptance and commitment therapy for demoralization syndrome and cancer-related trauma: A randomized clinical trial study (2021) · cites this paper as [11]
The Introduction says ACT is designed to maximize psychological flexibility in navigating life’s challenges, and the Discussion proposes that greater flexibility allows more adaptive responses to cancer-related challenges. But this was a pilot trial in breast cancer survivors with fear of recurrence; it does not establish a significant capacity for pattern change across patients with cancer and survivors generally. (LLM, conf=0.82)
Experimental — accuracy not yet measuredQuality of life significantly improved following ACT-based interventions.
“Studies reported significant improvement in QoL following the ACT-based interventions, post-intervention [44, 45, 48], and at follow-up periods of 1 and 6 months [44].”
From Acceptance and commitment therapy in adult cancer survivors: a systematic review and conceptual model (2021) · cites this paper as [44]
Most studies used ACT processes exclusively, while others used ACT as a hybrid therapy with CBT, relaxation, metacognitive therapy, or other models.
“ACT processes were used exclusively in about 64% of the studies [44, 46, 52–55] (unpublished thesis). The other studies used ACT as a hybrid therapy, where the intervention involved both ACT and other therapies, such as CBT and relaxation [51], metacognitive therapy [47, 48, 51], cognitive-behavioral stress management and mindfulness-based stress reduction [45], and processes of the Common-Sense Model of illness and the Self-Regulatory Executive Function model [47, 48].”
From Acceptance and commitment therapy in adult cancer survivors: a systematic review and conceptual model (2021) · cites this paper as [44]
Both pilot RCTs demonstrated moderate to large effects of ACT on psychological outcomes.
“Both studies demonstrated moderate to large effects of ACT on psychological outcomes [11, 12].”
From Symptom experiences in post-treatment cancer survivors: associations with acceptance and commitment therapy constructs. (2021) · cites this paper as [12]
Another pilot RCT found that compared to survivorship education and enhanced usual care, group-based ACT was effective in reducing breast cancer survivors' fear of cancer recurrence, general anxiety, and depressive symptoms at 6-month follow-up.
“Another pilot RCT found that compared to survivorship education and enhanced usual care, group-based ACT was effective in reducing breast cancer survivors’ fear of cancer recurrence, general anxiety, and depressive symptoms at 6-month follow-up [12].”
From Symptom experiences in post-treatment cancer survivors: associations with acceptance and commitment therapy constructs. (2021) · cites this paper as [12]
Five of the 13 articles reported results from published randomized controlled trials.
“Of the 13 articles, 5 reported results from published randomized controlled trials [44, 48–50, 53].”
From Acceptance and commitment therapy in adult cancer survivors: a systematic review and conceptual model (2021) · cites this paper as [44]
The mean age of participants across the 11 studies was 50.6 years, with study means ranging from 37.6 to 58.7 years.
“The mean age of participants across the 11 studies was 50.6 years, ranging from 37.6 years [51] to 58.7 years [44].”
From Acceptance and commitment therapy in adult cancer survivors: a systematic review and conceptual model (2021) · cites this paper as [44]
Experimental — accuracy not yet measuredSeven studies included only participants with a single cancer type, while four studies included participants with different cancer types.
“Seven studies included only participants with a single type of cancer (breast cancer [44, 54, 55] (Gardner), ovarian cancer [45], brain tumor [52], or testicular cancer [51]), while the other four studies included participants with different types of cancer [46–48, 53].”
From Acceptance and commitment therapy in adult cancer survivors: a systematic review and conceptual model (2021) · cites this paper as [44]
About 64% of studies used ACT processes exclusively.
“ACT processes were used exclusively in about 64% of the studies [44, 46, 52–55] (unpublished thesis).”
From Acceptance and commitment therapy in adult cancer survivors: a systematic review and conceptual model (2021) · cites this paper as [44]
Sample size justification or power description was reported for only two of the 11 studies (18%).
“Sample size justification or power description was reported for only two (18%) of the 11 studies [44, 48].”
From Acceptance and commitment therapy in adult cancer survivors: a systematic review and conceptual model (2021) · cites this paper as [44]
About 36% of studies used an active comparator.
“An active comparator was used in about 36% of the studies [44, 48, 53] (unpublished thesis).”
From Acceptance and commitment therapy in adult cancer survivors: a systematic review and conceptual model (2021) · cites this paper as [44]
Only two studies reported use of intent-to-treat analyses.
“Some studies also did not employ adequate statistical approaches; only two studies reported use of intent-to-treat analyses [44, 48], and only one study [46] assessed the outcome measure multiple times before the intervention.”
From Acceptance and commitment therapy in adult cancer survivors: a systematic review and conceptual model (2021) · cites this paper as [44]
Four studies included only participants with clinically significant anxiety, depression, or fear of cancer recurrence.
“Four studies exclusively included participants with clinically significant anxiety, depression, or FCR [44, 48, 52, 54].”
From Acceptance and commitment therapy in adult cancer survivors: a systematic review and conceptual model (2021) · cites this paper as [44]
Only one article reported blinding of participants.
“However, some aspects of methodological quality were widely ignored; for example, only one article reported blinding of participants [44], while the others gave no information about whether the participants were aware of the study hypotheses.”
From Acceptance and commitment therapy in adult cancer survivors: a systematic review and conceptual model (2021) · cites this paper as [44]
Our team's previous work showed feasibility and promise of ACT in reducing fear of recurrence and symptoms of anxiety and depression in breast cancer survivors.
“Based on our team’s previous work showing the feasibility and promise of ACT in reducing fear of recurrence and symptoms of anxiety and depression in breast cancer survivors [50]”
From Co-Designing the MOSAIC mHealth App With Breast Cancer Survivors: User-Centered Design Approach (2024) · cites this paper as [50]
Several ACT trials with cancer populations have noted post-intervention improvements in outcomes such as psychological distress and quality of life, although all have methodological limitations.
“Although all have methodological limitations, several ACT trials with cancer populations have noted post-intervention improvements in outcomes, such as psychological distress and quality of life [28, 33–36].”
Female cancer survivors predominated: six studies had only female participants, and the remaining studies had 75% to 95% female participants.
“Female cancer survivors were predominant, with six studies having only female participants [44, 45, 47, 54, 55] (unpublished thesis) and the others with percentage female ranging from 75% [52] to 95% [48].”
From Acceptance and commitment therapy in adult cancer survivors: a systematic review and conceptual model (2021) · cites this paper as [44]
The Methods (Participants) describe eligibility for breast cancer survivors, and the Results (Participant Characteristics) report age and other demographics, but neither gives participants’ sex or states that all were female. Searches for “women” and “female 100% sex gender women” found no passage establishing the female-only figure attributed to this study. This paper also cannot establish the counts or percentages for the other studies in the citing sentence. (LLM, conf=0.70)
Experimental — accuracy not yet measuredTwo included studies had low risk of bias and received a good quality rating on the NIH quality assessment tool.
“Among the included studies, two had a low risk of bias and received a good quality rating as per the NIH quality assessment tool [44, 48].”
From Acceptance and commitment therapy in adult cancer survivors: a systematic review and conceptual model (2021) · cites this paper as [44]
The Methods (Procedures and Statistical Analysis; page unavailable) describe this pilot randomized trial, including allocation concealment and intent-to-treat analysis. Our copy does not report an NIH quality-assessment rating or a low-risk-of-bias judgment; searches for those terms found no such assessment. The citing document’s rating cannot be verified from this source alone. (LLM, conf=0.76)
Experimental — accuracy not yet measuredA pilot RCT found that a six-session ACT group intervention produced a reduction in FCR severity and an increase in QoL pre, post and follow-up in women who had completed treatment for breast cancer.
“The results found that the ACT intervention was able to produce a reduction in measures of FCR severity and increase in QoL, pre, post and follow-up.”
From Real-world evaluation of an acceptance and commitment therapy–based group programme for breast cancer survivors with fear of cancer recurrence (2023) · cites this paper as [16]
Cites
A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.10.1092 · Cited by 31,765 · see citing works
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160 · see citing works
Self-citationThe PHQ-8 as a measure of current depression in the general population
Kroenke, K., Strine, T. W., Spitzer, R. L., Williams, J. B. W., Berry, J. T., & Mokdad, A. H. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.06.026 · Cited by 5,121 · see citing works
The Impact of Event Scale: Revised
Weiss, D. S. (2007) · Springer eBooks · doi:10.1007/978-0-387-70990-1_10 · Cited by 3,008 · see citing works
Ironic processes of mental control.
Wegner, D. M. (1994) · Psychological Review · doi:10.1037//0033-295x.101.1.34 · Cited by 2,609 · cited 1× · see citing works
“Although avoidant coping allows survivors to escape anxiety-provoking thoughts about cancer in the short term, rebound effects produce sustained, elevated levels of FCR over time.(42) This may explain why the impact of ACT was greatest at T4.”
BackgroundHays, R. D., Bjorner, J. B., Revicki, D. A., Spritzer, K. L., & Cella, D. (2009) · Quality of Life Research · doi:10.1007/s11136-009-9496-9 · Cited by 1,957 · see citing works
Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies
Simard, S., Thewes, B., Humphris, G., Dixon, M., Hayden, C., Mireskandari, S., & Ozakinci, G. (2013) · Journal of Cancer Survivorship · doi:10.1007/s11764-013-0272-z · Cited by 1,217 · cited 6× · see citing works
“5 million American BCS are expected to survive ≥5 years after treament,(7) up to 70% of survivors report clinically significant FCR,(8,9) making it the most frequently reported unmet need of BCS.(1,10) Left untreated, debilitating fears may linger throughout survivorship,(1,2) thereby reducing quality of life (QOL).”
BackgroundInfluentialHayes, S. C., Levin, M. E., Plumb-Vilardaga, J., Villatte, J. L., & Pistorello, J. (2013) · Behavior Therapy · doi:10.1016/j.beth.2009.08.002 · Cited by 1,120 · cited 1× · see citing works
“Over 6 weekly 2-hour sessions, ACT sought to reduce the impact of FCR by promoting adaptive strategies for responding to fear.(31) Led by a doctoral-level provider trained in mindfulness and acceptance-based therapies, each session included mindfulness exercises to deepen present-moment awareness.”
MethodSimard, S., & Savard, J. (2009) · Supportive Care in Cancer · doi:10.1007/s00520-008-0444-y · Cited by 608 · see citing works
Lebel, S., Ozakinci, G., Humphris, G., Mutsaers, B., Thewes, B., Prins, J., Dinkel, A., Butow, P., & on behalf of the University of Ottawa Fear of Cancer Recurrence Colloquium attendees (2016) · Supportive Care in Cancer · doi:10.1007/s00520-016-3272-5 · Cited by 586 · see citing works
Koch, L., Jansen, L., Brenner, H., & Arndt, V. (2013) · Psycho-Oncology · doi:10.1002/pon.3022 · Cited by 511 · cited 1× · see citing works
“Left untreated, debilitating fears may linger throughout survivorship,(1,2) thereby reducing quality of life (QOL).(1,2,8,11,12) Many BCS manage FCR with maladaptive hypervigilant or avoidant coping.”
BackgroundTesting for baseline balance in clinical trials
Senn, S. (1994) · Statistics in Medicine · doi:10.1002/sim.4780131703 · Cited by 503 · see citing works
The truly remarkable universality of half a standard deviation: confirmation through another look
Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2004) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.4.5.581 · Cited by 490 · cited 1× · see citing works
“Betweengroup differences at each time point favored ACT, most obviously at T4; 6 months after the intervention, ACT participants reported greater reductions in FCR severity compared with both SE and EUC participants, with differences large enough to be considered clinically significant.(40) Moderate to large improveme…”
ResultGraham, C. D., Gouick, J., Krahé, C., & Gillanders, D. (2016) · Clinical Psychology Review · doi:10.1016/j.cpr.2016.04.009 · Cited by 476 · see citing works
Factors reported to influence fear of recurrence in cancer patients: a systematic review
Crist, J. V., & Grunfeld, E. A. (2013) · Psycho-Oncology · doi:10.1002/pon.3114 · Cited by 431 · cited 1× · see citing works
“Many BCS manage FCR with maladaptive hypervigilant or avoidant coping.(11,13) Hypervigilant coping may result in excessive monitoring through daily breast self-examinations or requests for unnecessary scans, whereas avoidant coping involves attempts to ignore thoughts of cancer.”
BackgroundFear of cancer progression and cancer‐related intrusive cognitions in breast cancer survivors
Mehnert, A., Berg, P., Henrich, G., & Herschbach, P. (2009) · Psycho-Oncology · doi:10.1002/pon.1481 · Cited by 354 · cited 3× · see citing works
“Although avoidance provides short-term stress reduction, such efforts often fail over time as thoughts of death become increasingly intrusive.(11,14) Cognitive behavioral therapy (CBT) is a common psychotherapeutic intervention for patients with FCR.”
BackgroundScreening and comorbidity of clinical levels of fear of cancer recurrence
Simard, S., & Savard, J. (2015) · Journal of Cancer Survivorship · doi:10.1007/s11764-015-0424-4 · Cited by 329 · cited 2× · see citing works
“Left untreated, debilitating fears may linger throughout survivorship,(1,2) thereby reducing quality of life (QOL).(1,2,8,11,12) Many BCS manage FCR with maladaptive hypervigilant or avoidant coping.”
BackgroundFear of cancer recurrence: specific profiles and nature of intrusive thoughts
Simard, S., Savard, J., & Ivers, H. (2010) · Journal of Cancer Survivorship · doi:10.1007/s11764-010-0136-8 · Cited by 229 · cited 1× · see citing works
“Characterized by maladaptive coping, intrusive thoughts, and excessive distress,(4) clinically significant FCR disproportionally affects breast cancer survivors (BCS) compared with survivors of other common cancers.(5,6) Although approximately 90% of the 3.”
BackgroundButow, P. N., Turner, J., Gilchrist, J., Sharpe, L., Smith, A. B., Fardell, J. E., Tesson, S., O’Connell, R., Girgis, A., Gebski, V. J., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.1257 · Cited by 228 · cited 2× · see citing works
“First, ACT can be delivered efficaciously to a group, thereby potentially reducing costs and increasing the number of those served compared to individually delivered interventions.(27,29) Second, it appears that targeting FCR while reducing maladaptive coping may promote concomitant reductions in distress outcomes.”
BackgroundHulbert-Williams, N. J., Storey, L., & Wilson, K. G. (2015) · European Journal of Cancer Care · doi:10.1111/ecc.12223 · Cited by 228 · cited 1× · see citing works
“Theoretically, reducing avoidant coping promotes psychological flexibility, allowing individuals to pursue more adaptive strategies to handle cancer-related and other challenges.(43) This interpretation is supported by the improvements in physical and mental QOL reported by ACT participants, which likely resulted from…”
BackgroundFeros, D. L., Lane, L., Ciarrochi, J., & Blackledge, J. T. (2013) · Psycho-Oncology · doi:10.1002/pon.2083 · Cited by 216 · see citing works
the FCR Study Advisory Committee, Thewes, B., Butow, P., Bell, M. L., Beith, J., Stuart-Harris, R., Grossi, M., Capp, A., & Dalley, D. (2012) · Supportive Care in Cancer · doi:10.1007/s00520-011-1371-x · Cited by 213 · see citing works
van de Wal, M., Thewes, B., Gielissen, M., Speckens, A., & Prins, J. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.5301 · Cited by 195 · cited 1× · see citing works
“Only 2 FCRI subscales (ie, Reassurance Seeking and Coping Strategies) failed to demonstrate significant differences, a finding that is consistent with reports from other recent studies.(18,41) Although preliminary, the results of the current study are promising for several reasons.”
ResultPrimary Health and Supportive Care Needs of Long-Term Cancer Survivors: A Questionnaire Survey
Harrison, S. E., Watson, E. K., Ward, A. M., Khan, N. F., Turner, D., Adams, E., Forman, D., Roche, M. F., & Rose, P. W. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.5167 · Cited by 176 · cited 4× · see citing works
“Despite these limitations, the results of the current study suggest that ACT is a promising treatment for reducing FCR in BCS. Unlike SE or EUC, ACT may reduce maladaptive avoidant coping, thereby contributing to the long-term management of FCR and associated distress.”
BackgroundInfluentialMind‐body interventions for fear of cancer recurrence: A systematic review and meta‐analysis
Hall, D. L., Luberto, C. M., Philpotts, L. L., Song, R., Park, E. R., & Yeh, G. Y. (2018) · Psycho-Oncology · doi:10.1002/pon.4757 · Cited by 159 · see citing works
Evaluation of two group therapies to reduce fear of progression in cancer patients
Herschbach, P., Book, K., Dinkel, A., Berg, P., Waadt, S., Duran, G., Engst-Hastreiter, U., & Henrich, G. (2010) · Supportive Care in Cancer · doi:10.1007/s00520-009-0696-1 · Cited by 145 · cited 1× · see citing works
“57).(16,19-21) It is interesting to note that CBT produced a moderate effect (≥−0.”
BackgroundTaking CHARGE: a self-management program for women following breast cancer treatment
Cimprich, B., Janz, N. K., Northouse, L., Wren, P. A., Given, B., & Given, C. W. (2005) · Psycho-Oncology · doi:10.1002/pon.891 · Cited by 134 · cited 1× · see citing works
“SE covered relevant survivorship topics (eg, symptom management, weight management, physical activity, and survivorship care plans).(33,34) Didactic discussions were guided by masters-level oncology social workers.”
BackgroundSavard, J., & Ivers, H. (2013) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2012.12.013 · Cited by 131 · see citing works
Ellegaard, M.-B. B., Grau, C., Zachariae, R., & Bonde Jensen, A. (2017) · Acta Oncologica · doi:10.1080/0284186x.2016.1268714 · Cited by 128 · see citing works
Cancer Distress Reduction with a Couple-Based Skills Training: A Randomized Controlled Trial
Heinrichs, N., Zimmermann, T., Huber, B., Herschbach, P., Russell, D. W., & Baucom, D. H. (2012) · Annals of Behavioral Medicine · doi:10.1007/s12160-011-9314-9 · Cited by 128 · see citing works
Dieng, M., Butow, P. N., Costa, D. S. J., Morton, R. L., Menzies, S. W., Mireskandari, S., Tesson, S., Mann, G. J., Cust, A. E., & Kasparian, N. A. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.2278 · Cited by 123 · see citing works
Koch-Gallenkamp, L., Bertram, H., Eberle, A., Holleczek, B., Schmid-Höpfner, S., Waldmann, A., Zeissig, S. R., Brenner, H., & Arndt, V. (2016) · Health Psychology · doi:10.1037/hea0000374 · Cited by 107 · cited 1× · see citing works
“Characterized by maladaptive coping, intrusive thoughts, and excessive distress,(4) clinically significant FCR disproportionally affects breast cancer survivors (BCS) compared with survivors of other common cancers.(5,6) Although approximately 90% of the 3.”
BackgroundThewes, B., Lebel, S., Seguin Leclair, C., & Butow, P. (2016) · Supportive Care in Cancer · doi:10.1007/s00520-015-3025-x · Cited by 104 · cited 2× · see citing works
“Hypervigilant coping may result in excessive monitoring through daily breast self-examinations or requests for unnecessary scans, whereas avoidant coping involves attempts to ignore thoughts of cancer.(1,14) Although avoidance provides short-term stress reduction, such efforts often fail over time as thoughts of death…”
BackgroundArch, J. J., & Mitchell, J. L. (2016) · Psycho-Oncology · doi:10.1002/pon.3890 · Cited by 103 · cited 1× · see citing works
“Cancer-related avoidant coping was measured using the 17-item Cancer Acceptance and Action Questionnaire with items rated on a 7-point scale (with 1 indicating never true and 7 indicating always true).(28) Distress measures included the Generalized Anxiety Disorder 7-item scale(36) and 8-item Patient Health Questionna…”
MethodGermino, B. B., Mishel, M. H., Crandell, J., Porter, L., Blyler, D., Jenerette, C., & Gil, K. M. (2013) · Oncology Nursing Forum · doi:10.1188/13.onf.82-92 · Cited by 83 · cited 1× · see citing works
“Several CBT trials have included FCR as a primary(16-19) or secondary outcome.(20,21) Although CBT has proven superior to usual care in reducing FCR (reported effect sizes of −0.”
The Use of Acceptance and Commitment Therapy in Oncology Settings: A Narrative Review
Fashler, S. R., Weinrib, A. Z., Azam, M. A., & Katz, J. (2018) · Psychological Reports · doi:10.1177/0033294117726061 · Cited by 80 · see citing works
(2015) · Europe PMC (PubMed Central) · Cited by 68 · see citing works
Merckaert, I., Lewis, F., Delevallez, F., Herman, S., Caillier, M., Delvaux, N., Libert, Y., Liénard, A., Nogaret, J., Ogez, D., et al. (2017) · Psycho-Oncology · doi:10.1002/pon.4294 · Cited by 53 · cited 1× · see citing works
“Several CBT trials have included FCR as a primary(16-19) or secondary outcome.(20,21) Although CBT has proven superior to usual care in reducing FCR (reported effect sizes of −0.”
Psychometric properties of the Fear of Cancer Recurrence Inventory: an item response theory approach
Costa, D. S. J., Dieng, M., Cust, A. E., Butow, P. N., & Kasparian, N. A. (2015) · Psycho-Oncology · doi:10.1002/pon.4018 · Cited by 46 · cited 1× · see citing works
“Only 2 FCRI subscales (ie, Reassurance Seeking and Coping Strategies) failed to demonstrate significant differences, a finding that is consistent with reports from other recent studies.(18,41) Although preliminary, the results of the current study are promising for several reasons.”
ResultBreast Cancer Survivorship Program
Chung, L. K., Cimprich, B., Janz, N. K., & Mills-Wisneski, S. M. (2009) · Cancer Nursing · doi:10.1097/ncc.0b013e318196c67b · Cited by 35 · cited 1× · see citing works
“SE covered relevant survivorship topics (eg, symptom management, weight management, physical activity, and survivorship care plans).(33,34) Didactic discussions were guided by masters-level oncology social workers.”
BackgroundWorry about Breast Cancer Recurrence: A Population-based Analysis
Tewari, A., & Chagpar, A. B. (2014) · The American Surgeon™ · doi:10.1177/000313481408000716 · Cited by 31 · cited 1× · see citing works
“Left untreated, debilitating fears may linger throughout survivorship,(1,2) thereby reducing quality of life (QOL).(1,2,8,11,12) Many BCS manage FCR with maladaptive hypervigilant or avoidant coping.”
BackgroundMontesinos, F., & Luciano, C. (2016) · Psicooncologia · doi:10.5209/rev_psic.2016.v13.n1.52484 · Cited by 15 · cited 1× · see citing works
“First, ACT can be delivered efficaciously to a group, thereby potentially reducing costs and increasing the number of those served compared to individually delivered interventions.(27,29) Second, it appears that targeting FCR while reducing maladaptive coping may promote concomitant reductions in distress outcomes.”
Background(2012) · doi:10.1037/17335-004 · Cited by 2
Flagged first, then by citations
Research works printed but not linked: 1
- Weiss D, 1997, Assessing Psychological Trauma and PTSD: A Practioner's Handbook, 339
Cited by
Sorted by citations
Breast cancer: pathogenesis and treatments
Xiong, X., Zheng, L., Ding, Y., Chen, Y., Cai, Y., Wang, L., Huang, L., Liu, C., Shao, Z., & Yu, K. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02108-4 · Cited by 1,098 · see citing works
Luigjes‐Huizer, Y. L., Tauber, N. M., Humphris, G., Kasparian, N. A., Lam, W. W. T., Lebel, S., Simard, S., Smith, A. B., Zachariae, R., Afiyanti, Y., et al. (2022) · Psycho-Oncology · doi:10.1002/pon.5921 · Cited by 332 · see citing works
Zhao, C., Lai, L., Zhang, L., Cai, Z., Ren, Z., Shi, C., Luo, W., & Yan, Y. (2021) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2020.110304 · Cited by 104 · see citing works
Mathew, A., Doorenbos, A. Z., Jang, M. K., & Hershberger, P. E. (2021) · Journal of Cancer Survivorship · doi:10.1007/s11764-020-00938-z · Cited by 91 · see citing works
Li, H., Wong, C. L., Jin, X., Chen, J., Chong, Y. Y., & Bai, Y. (2021) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2021.103876 · Cited by 81 · see citing works
Lyu, M., Siah, R. C., Lam, A. S. L., & Cheng, K. K. F. (2022) · Journal of Advanced Nursing · doi:10.1111/jan.15321 · Cited by 77 · see citing works
Durosini, I., Triberti, S., Savioni, L., Sebri, V., & Pravettoni, G. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191912704 · Cited by 80 · see citing works
“, 2020 [54] Evidencebased interventions 91 breast cancer survivors Intervention to examine the feasibility and preliminary efficacy of group-based acceptance commitment therapy (ACT, focused on coping strategies) for fear of recurrence and quality of life, compared with survivor education and usual care All interventi…”
BackgroundMethodPsychoeducation for breast cancer: A systematic review and meta-analysis
Setyowibowo, H., Yudiana, W., Hunfeld, J. A. M., Iskandarsyah, A., Passchier, J., Arzomand, H., Sadarjoen, S. S., de Vries, R., & Sijbrandij, M. (2022) · The Breast · doi:10.1016/j.breast.2022.01.005 · Cited by 74 · see citing works
“, 2020 [51] BC survivors Clinic; US (HIC) Survivorship education 32 6 weeks (6 sessions) Survivorship education coving relevant survivorship topics: symptom management, weight”
BackgroundPradhan, P., Sharpe, L., & Menzies, R. E. (2021) · Cancer Management and Research · doi:10.2147/cmar.s294114 · Cited by 60 · see citing works
Konstantinou, P., Ioannou, M., Melanthiou, D., Georgiou, K., Almas, I., Gloster, A. T., Kassianos, A. P., & Karekla, M. (2023) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2023.08.004 · Cited by 53 · see citing works
Park, S.-Y., & Lim, J.-W. (2022) · BMC Cancer · doi:10.1186/s12885-021-08909-y · Cited by 53 · see citing works
“[38] included both a comparison group (e.”
BackgroundMethodInfluentialLi, H., Wu, J., Ni, Q., Zhang, J., Wang, Y., & He, G. (2021) · Nursing Research · doi:10.1097/nnr.0000000000000499 · Cited by 48 · see citing works
Li, Y., Fang, C., Xiong, M., Hou, H. B., Zhang, Y., & Zhang, C. (2023) · Journal of Advanced Nursing · doi:10.1111/jan.16009 · Cited by 54 · see citing works
Vachon, E. A., Krueger, E., Champion, V. L., Haggstrom, D. A., Cella, D. F., & Cohee, A. A. (2020) · Psycho-Oncology · doi:10.1002/pon.5568 · Cited by 46 · see citing works
“The primary independent variable for this secondary analysis was FCR. FCR was measured utilizing the Concerns About Recurrence Scale (CARS) Total Worries Index.23 The CARS Total Worries Index includes 28 items on a 0 (“Not at all”)–5 (“All or most of the time”) scale that are summed together for a FCR total worries sc…”
BackgroundInfluentialSelf-citationRecent trends in the management of depression in persons with cancer
Panjwani, A. A., & Li, M. (2021) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000727 · Cited by 41 · see citing works
Fowler, N. R., Judge, K. S., Lucas, K., Gowan, T., Stutz, P., Shan, M., Wilhelm, L., Parry, T., & Johns, S. A. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02078-0 · Cited by 39 · see citing works
“using a structured fidelity checklist similar to the one used in our previous ACT interventions [36].”
MethodSelf-citationInsomnia and Susceptibility to Depressive Symptoms and Fatigue in Diverse Breast Cancer Survivors
Haque, R., Hsu, J.-W. Y., Avila, C., Olmstead, R., Carroll, J., & Irwin, M. R. (2020) · Journal of Women's Health · doi:10.1089/jwh.2019.8135 · Cited by 37 · see citing works
Jiang, X., Sun, J., Song, R., Wang, Y., Li, J., & Shi, R. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1253266 · Cited by 43 · see citing works
Nair, D., Bonnet, K. R., Wild, M. G., Umeukeje, E. M., Fissell, R. B., Faulkner, M. L., Bahri, N. S., Bruce, M. A., Schlundt, D. G., Wallston, K. A., et al. (2020) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2020.07.014 · Cited by 37 · see citing works
Remote Psychological Interventions for Fear of Cancer Recurrence: Scoping Review.
Cincidda, C., Pizzoli, S. F. M., & Pravettoni, G. (2022) · JMIR Cancer · doi:10.2196/29745 · Cited by 34 · see citing works
“The retrieved studies in the literature on ACT reported only protocols and feasibility or qualitative studies, with no quantitative data on the effectiveness of such an approach, except for 2 RCTs—1 that provided a face-to-face intervention and the other 1 a web-based intervention [35-37,57].”
BackgroundInfluentialMartínez-Miranda, P., Casuso-Holgado, M. J., & Jiménez‐Rejano, J. (2021) · Clinical Rehabilitation · doi:10.1177/02692155211031081 · Cited by 33 · see citing works
Paperák, P., Javůrková, A., & Raudenská, J. (2023) · Journal of Cancer Survivorship · doi:10.1007/s11764-022-01277-x · Cited by 31 · see citing works
Trindade, I. A., Ferreira, C., & Pinto-Gouveia, J. (2020) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2019.12.005 · Cited by 31 · see citing works
Shari, N. I., Zainal, N. Z., & Ng, C. G. (2021) · Journal of Psychosocial Oncology · doi:10.1080/07347332.2020.1856283 · Cited by 28 · see citing works
Lewson, A. B., Johns, S. A., Krueger, E., Chinh, K., Kidwell, K. M., & Mosher, C. E. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-020-05854-7 · Cited by 29 · see citing works
Self-citationGreen, S. M. C., French, D., Graham, C. D., Hall, L., Rousseau, N. S., Foy, R., Clark, J., Parbutt, C., Raine, E., Gardner, B., et al. (2022) · BMC Health Services Research · doi:10.1186/s12913-022-08243-4 · Cited by 31 · see citing works
“For example, ACT-based skills that help one ‘unhook’ from distressing thoughts, could positively affect emotional representations, such as reducing fear of recurrence [147].”
BackgroundAn update on breast cancer chemotherapy-associated toxicity and their management approaches
Langeh, U., Kumar, V., Ahuja, P., Singh, C., & Singh, A. (2023) · Health Sciences Review · doi:10.1016/j.hsr.2023.100119 · Cited by 31 · see citing works
Zhang, Y., Ding, Y., Chen, X., Li, Y., Li, J., & Hu, X. (2023) · Worldviews on Evidence-Based Nursing · doi:10.1111/wvn.12652 · Cited by 26 · see citing works
Jaafar, N. R. N., Hamid, N. A., Hamdan, N. A., Rajandram, R. K., Mahadevan, R., Yunus, M. R. M., ZAKARIA, R. H., & Abdullah, M. F. I. L. B. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.716674 · Cited by 28 · see citing works
Unmet supportive care needs, anxiety and depression in haematology patients during watch‐and‐wait
Damen, M. D. C., Westerweel, P. E., Levin, M. D., & Pelle, A. J. M. (2021) · Psycho-Oncology · doi:10.1002/pon.5800 · Cited by 25 · see citing works
Benedict, C., Stal, J., Davis, A., Zeidman, A., Pons, D., Schapira, L., Diefenbach, M. A., & Ford, J. S. (2023) · Psycho-Oncology · doi:10.1002/pon.6212 · Cited by 26 · see citing works
“45,46 Alternatively, as survivors have reportedexistentialdistress relatedtooncofertilityconcerns(e.g.,loss of womanhood, identity renegotiation, and loss of meaning and purpose), Meaning ‐ Centered Psychotherapy may help survivors identify sources of meaning in reaction to their new reality of…”
Tauber, N. M., Zachariae, R., Jensen, A. B., Thewes, B., Skyt, I., Elkjær, E., Butow, P. N., & O’Toole, M. S. (2022) · Psycho-Oncology · doi:10.1002/pon.5772 · Cited by 22 · see citing works
“Our preliminary results are thus comparable or better than those of the RCTof individually deliveredConquerFear (d =0.33–0.46), and alignwell with bothmeta‐analytic evidence18 and the findings of other recent studies on group‐based therapies for FCR.36,37 Although CF‐”
ResultInfluentialSadeghi-Bahmani, D., Esmaeili, L., Mokhtari, F., Sadeghi Bahmani, L., Afsharzadeh, M., Shaygannejad, V., Mirmosayyeb, O., Goldstein-Piekarski, A. N., & Gross, J. J. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.104029 · Cited by 22 · see citing works
Rosendahl, J., Gawlytta, R., Ressel, E., Rodeck, J., Strauss, B. M., Mehnert, A., & Koranyi, S. (2023) · Psycho-Oncology · doi:10.1002/pon.6082 · Cited by 23 · see citing works
Outlining an Acceptance and Commitment Therapy approach to treatment non‐adherence
Graham, C. D., McCracken, L. M., Harrison, A., Walburn, J., & Weinman, J. (2022) · British Journal of Health Psychology · doi:10.1111/bjhp.12579 · Cited by 22 · see citing works
Kang, N., & Yu, E. (2023) · Psycho-Oncology · doi:10.1002/pon.6199 · Cited by 20 · see citing works
Chen, R., Yang, H., Zhang, H., Chen, J., Liu, S., & Li, W. (2023) · BMC Psychology · doi:10.1186/s40359-023-01211-5 · Cited by 23 · see citing works
“The interventions including cognitive behavior therapy [46], mindfulness-based cognitive therapy [47], acceptance and commitment therapy [48], and problem-solving therapy [49] are recommended.”
BackgroundSalari, N., Rezaie, L., Khazaie, H., Bokaee, S., Ghasemi, H., Mohammadi, M., & Khaledi-Paveh, B. (2023) · Current Psychology · doi:10.1007/s12144-021-01934-x · Cited by 21 · see citing works
Luigjes‐Huizer, Y. L., Helsper, C. W., de Wit, N. J., & van der Lee, M. L. (2023) · Psycho-Oncology · doi:10.1002/pon.6231 · Cited by 18 · see citing works
“…specialised interventions scored the same or somewhat better, for example, ConquerFear 2.3 points difference in FCR reduction, 35 ACT 2.3 points 36 and SWORD 4.0 points 37 ; and low intensity interventions scored the same or somewhat worse than our intervention, for example, a psycho -…”
BackgroundInfluentialMisra, A., Bryan, A., S. Faber, N., Printz Pereira, D., Faber, S., T. Williams, M., & D. Skinta, M. (2023) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2023.05.008 · Cited by 21 · see citing works
Smith, S. G., Ellison, R., Hall, L., Clark, J., Hartley, S., Mason, E., Metherell, J., Olivier, C., Napp, V., Naik, J., et al. (2022) · Pilot and Feasibility Studies · doi:10.1186/s40814-022-00985-6 · Cited by 17 · see citing works
Fear of cancer recurrence and coping attitudes of breast cancer survivors
Öztaş, B., Uğurlu, M., & Kurt, G. (2022) · European Journal of Cancer Care · doi:10.1111/ecc.13742 · Cited by 17 · see citing works
Wang, X., Chen, J., Liu, Y.-E., & Wu, Y. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/8538656 · Cited by 16 · see citing works
Sarizadeh, M. S., Rahimian Boogar, I., Talepasand, S., & Gharemanfard, F. (2021) · International Journal of Cancer Management · doi:10.5812/ijcm.114637 · Cited by 15 · see citing works
Li, L., & Su, Y. (2024) · Asian Nursing Research · doi:10.1016/j.anr.2024.10.003 · Cited by 19 · see citing works
Martínez-Miranda, P., Jiménez‐Rejano, J., Rosales‐Tristancho, A., & Casuso-Holgado, M. J. (2023) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2023.102411 · Cited by 12 · see citing works
Wang, X., Wang, N., Zhong, L. L. D., Su, K., Wang, S., Zheng, Y., Yang, B., Zhang, J., Pan, B., Yang, W. P., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.879563 · Cited by 13 · see citing works
Moreno, P. I., Horner, F. S., Torzewski, J. B., Thomas, J. L., Gradishar, W., Victorson, D., & Penedo, F. J. (2022) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2021.100870 · Cited by 12 · see citing works
Emotional Problems Prior to Adjuvant Radiation Therapy for Breast Cancer
Rades, D., NARVAEZ, C. A., Dziggel, L., et al. (2021) · In Vivo · doi:10.21873/invivo.12561 · Cited by 13 · see citing works
Pehlivan, M., & Eyı, S. (2024) · Cancer Nursing · doi:10.1097/ncc.0000000000001427 · Cited by 19 · see citing works
Hassani Alimolk, F., McDonald, F. E. J., Asghari‐Jafarabadi, M., Ahmadi, F., Zenoozian, S., Lashkari, M., & Patterson, P. (2024) · Psycho-Oncology · doi:10.1002/pon.6339 · Cited by 13 · see citing works
“22 Second, when patients get fused with their minds' stories about cancer progression, they often use maladaptive coping, such as experiential avoidance.”
BackgroundResultInfluentialZhao, J., Wang, M., Huang, R., Xu, J., Chen, G., Yu, S., Tang, L., Yao, S., Li, W., & Cheng, H. (2023) · Supportive Care in Cancer · doi:10.1007/s00520-023-07929-7 · Cited by 12 · see citing works
Mosher, C. E., Seçinti, E., Kroenke, K., Helft, P. R., Turk, A. A., Loehrer, P. J., Sehdev, A., Al-Hader, A. A., Champion, V. L., & Johns, S. A. (2021) · Pilot and Feasibility Studies · doi:10.1186/s40814-021-00837-9 · Cited by 10 · see citing works
“Although preliminary evidence suggests that ACT improves QoL outcomes in patients with cancer and other chronic conditions [25, 26, 28, 29, 31, 45], these trials have almost exclusively focused on patients.”
BackgroundMethodSelf-citationRisk factors for worse anxiety trajectories among patients undergoing cancer chemotherapy
Suskin, J. A., Paul, S. M., Stuckey, A. R., Conley, Y. P., Miaskowski, C. A., & Dunn, L. B. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-022-07481-w · Cited by 11 · see citing works
Suskin, J. A., Paul, S. M., Stuckey, A. R., Conley, Y. P., Hammer, M. J., Miaskowski, C. A., & Dunn, L. B. (2022) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2022.102227 · Cited by 11 · see citing works
Yuyan, Y., Jiaqi, L., Ting, W., Juan, X., Jinfeng, W., & Jing, L. (2025) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2025.102862 · Cited by 11 · see citing works
Yang, Y., Yi, Y., Shi, X., & Yang, X. (2024) · Medicine · doi:10.1097/md.0000000000038155 · Cited by 13 · see citing works
Hall, L. H., Clark, J., Smith, S. G., Graham, C. D., & for the ACTION investigators (2022) · Journal of Psychosocial Oncology · doi:10.1080/07347332.2021.1955318 · Cited by 10 · see citing works
Song, W., Shari, N. I., Song, J., Zhang, R., Mansor, N. S., Leong Bin Abdullah, M. F. I., & Zhang, Z. (2024) · PLoS ONE · doi:10.1371/journal.pone.0312669 · Cited by 9 · see citing works
Cheng, S.-L., Yusuf, A., He, Y., et al. (2024) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s453184 · Cited by 9 · see citing works
“33,41 Positive personal resources were seen as an important coping resource.”
BackgroundSinclair, F., Gillanders, D., Rooney, N., Bonathan, C., Hendry, K., McLoone, P., & Hewitt, C. (2023) · Supportive Care in Cancer · doi:10.1007/s00520-023-08179-3 · Cited by 9 · see citing works
Fear of Cancer Recurrence in Sarcoma Survivors: Results from the SURVSARC Study
Pellegrini, I., Drabbe, C., Grünhagen, D. J., van de Sande, M. A. J., de Haan, J. J., Keymeulen, K., Bonenkamp, J. J., van der Graaf, W. T. A., & Husson, O. (2022) · Cancers · doi:10.3390/cancers14246099 · Cited by 10 · see citing works
“This last approach represents a feasible and promising treatment in breast cancer survivors with clinical FCR, reducing maladaptive coping while facilitating adaptive management of FCR [41].”
BackgroundLong-term fear of cancer recurrence in patients treated endoscopically for early Barrett’s neoplasia
Rosmolen, W. D., Pouw, R. E., Henegouwen, M. I. V. B., Bergman, J. J. G. H. M., Sprangers, M. A. G., & Nieuwkerk, P. T. (2022) · Diseases of the Esophagus · doi:10.1093/dote/doac083 · Cited by 9 · see citing works
McCready, D. M., Arem, H., Duarte, D. A., Dennis, K., Ball, N., Cafferty, L. A., Hinds, P. S., Howlader, A., & Berg, C. J. (2024) · Contemporary Clinical Trials · doi:10.1016/j.cct.2024.107545 · Cited by 8 · see citing works
‘Is it painful’? A qualitative study on experiences of patients before prostate needle biopsy
Mao, J., Dai, Y., Wang, L., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-056619 · Cited by 8 · see citing works
Al‐Abbadey, M., Tomescu‐Stachie, S., Kaklamanou, D., Jarrett, N., Merwood, A., Tyndall, I. T., & McCracken, L. M. (2025) · British Journal of Health Psychology · doi:10.1111/bjhp.12807 · Cited by 9 · see citing works
Effectiveness of Cognitive Behavioral Therapy on Fear of Cancer Recurrence in Breast Cancer
Wei, F., Yang, X., He, R., Hu, Z., & Wang, Y. (2024) · Cancer Nursing · doi:10.1097/ncc.0000000000001356 · Cited by 8 · see citing works
Nicolescu, S., Secară, E.-C., Jiboc, N. M., & Băban, A. (2024) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2024.100729 · Cited by 7 · see citing works
Gong, F.-X., Zhou, X., Niu, Z.-H., Mao, Y., Wang, Y.-M., Lv, M., Gao, X.-Q., Liu, W.-J., & Wang, H.-B. (2022) · Cancer Management and Research · doi:10.2147/cmar.s353370 · Cited by 7 · see citing works
“This may be because the appearance is far less troublesome than the tumor itself such as the fear of cancer recurrence(30) especially in the young, advanced tumor stage and low family income groups.(31) However, based on the above-mentioned oncologic safety, it is believed that while solving the appearance problems as…”
BackgroundKim, Y., Min, H., & An, H. J. (2025) · Journal of Cancer Survivorship · doi:10.1007/s11764-025-01774-9 · Cited by 8 · see citing works
Zhang, B., Zhang, R., Deng, H., Cui, P., Li, C., Yang, F., & Leong Bin Abdullah, M. F. I. (2023) · PLoS ONE · doi:10.1371/journal.pone.0294768 · Cited by 6 · see citing works
Lyu, M., Siah, C. J. R., Zhao, J., & Cheng, K. K. F. (2023) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2023.102360 · Cited by 6 · see citing works
Liu, J., Griva, K., & Mahendran, R. (2023) · Annals of Behavioral Medicine · doi:10.1093/abm/kaad023 · Cited by 8 · see citing works
Psychological Support for Cancer Patients
Khalid, S., Abbas, I., & Javed, S. (2023) · Cancer treatment and research · doi:10.1007/978-3-031-27156-4_13 · Cited by 7 · see citing works
Green, S. M. C., French, D., Graham, C. D., Hall, L., Rousseau, N. S., Foy, R., Clark, J., Parbutt, C., Raine, E., Gardner, B., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1239166/v1 · Cited by 6 · see citing works
Mosher, C. E., Krueger, E., Hirsh, A. T., Miller, K. D., Ballinger, T. J., Storniolo, A. M., Schneider, B. P., Newton, E. V., Champion, V. L., & Johns, S. A. (2020) · Contemporary Clinical Trials · doi:10.1016/j.cct.2020.106168 · Cited by 6 · see citing works
“Acceptance and Commitment Therapy (ACT)—Study team members developed the ACT manual, which was informed by literature on fatigue and related symptoms in MBC patients [1, 2, 4], the ACT model [12, 15], previous ACT trials with patients with cancer and other chronic conditions [14, 17, 18, 20, 31, 32], and our clinical…”
MethodSelf-citationMirzaei, S., Bagherian-Sararoudi, R., Davazdahemami, M. H., Izadi, R., & Sharbafchi, M. R. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06823-2 · Cited by 6 · see citing works
Fear of the Cancer Coming Back: A Metasynthesis of Fear of Recurrence in Breast Cancer
Wang, K., Li, H., & Qin, N. (2024) · Public Health Nursing · doi:10.1111/phn.13467 · Cited by 5 · see citing works
Co-Designing the MOSAIC mHealth App With Breast Cancer Survivors: User-Centered Design Approach
Nuseibeh, B. Z., Johns, S. A., Shih, P. C., Lewis, G. F., Gowan, T. M., & Jordan, E. J. (2024) · JMIR Formative Research · doi:10.2196/59426 · Cited by 5 · see citing works
Self-citationDeng, H., Zhang, R., Wang, C., Zhang, B., Wang, J., Wang, S., Zhang, J., Shari, N. I., & Leong Bin Abdullah, M. F. I. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1215963 · Cited by 5 · see citing works
Sakai, M., Kondo, M., Sugiura, T., & Akechi, T. (2022) · Japanese Psychological Research · doi:10.1111/jpr.12422 · Cited by 5 · see citing works
D’Errico, D., Schroder, T. A., & Gresswell, D. M. (2022) · Psycho-Oncology · doi:10.1002/pon.5964 · Cited by 4 · see citing works
“In the RCTs, four studies had active comparators,34,37,38,42 three had a Waiting list (WL)33,36,41 one had Assessment only,28 and two had Enhanced Usual Care.34,35 Eleven studies12,28–30,32,33,36–40 targeted reduction of traumatic stress symptoms as their primary aim/outcome, whilst the remaining studies31,34,35,41,42…”
BackgroundGong, F.-X., Zhou, X., Niu, Z., et al. (2022) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 5 · see citing works
A Systematic and Meta-Analytical Review of Acceptance and Commitment Therapy for PTSD
Rehman, S., Ghazali, S. R., & Elklit, A. (2025) · Journal of Loss and Trauma · doi:10.1080/15325024.2025.2565354 · Cited by 9 · see citing works
“Secondly, the meta-analysis included studies from geographically limited regions, with seven based in the U.S. (Blevins et al., 2011; Boals & Murrell, 2016; Boals et al., 2015; Dindo et al., 2020; Johns et al., 2020; Lang et al., 2017; Moyer et al., 2018), and four with unspecified locations.”
Hockemeyer, N. G., Johns, S. A., Judge, K. S., Baucco, C., Gowan, T., Slaven, J. E., & Fowler, N. R. (2025) · Aging & Mental Health · doi:10.1080/13607863.2025.2453823 · Cited by 4 · see citing works
“Additionally, all TACTICs sessions were audio-recorded and assessed for fidelity and ACT skill level using a standardized fidelity checklist adopted from our previous ACT pilots (Fowler et al. 2021; Johns et al. 2020).”
Self-citationTrindade, I. A., Soares, A. M., Skvarc, D., Carreiras, D., Pereira, J., Lourenço, Ó. D., Sampaio, F., de Sousa, B. C., Martins, T., Boaventura, P., et al. (2025) · Trials · doi:10.1186/s13063-024-08626-4 · Cited by 4 · see citing works
“Nevertheless, ACT trials on BC are limited and more research is needed [22].”
Wei, F., He, R., Yang, X., Hu, Z., & Wang, Y. (2024) · BMJ Supportive & Palliative Care · doi:10.1136/spcare-2023-004639 · Cited by 6 · see citing works
Akzeptanz- und Commitment-Therapie (ACT) in der Psychoonkologie
Sauer, C., & Weißflog, G. (2022) · Der Onkologe · doi:10.1007/s00761-022-01127-6 · Cited by 4 · see citing works
“12 Monate nach Intervention) ↓ Distress (3/7 Studien sign., 4/5 im FU; kleine und große Effekte) ↓ Angst (6/9 Studien sign., 2/3 im FU, kleine – große Effekte) ↓ Depression (9/11 sign., 3/4 im FU, kleine und große Effekte) Studienmit zu geringer Qualität wurden ausgeschlossen Detaillierte Untersuchung von Distress, De…”
BackgroundSmith, S. G., Ellison, R., Hall, L., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-679400/v1 · Cited by 4 · see citing works
Cai, L., Chen, J., Su, J., Li, H., 方佳峰, & Chen, Z. (2026) · Acta Psychologica · doi:10.1016/j.actpsy.2026.106628 · Cited by 3 · see citing works
Dong, F., Yang, D., Dong, N., Li, Y., Wan, H., & Gao, J. (2024) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2024.111970 · Cited by 3 · see citing works
Zhu, X., Ren, G., Wang, J., Yan, Y., & Du, X. (2024) · Medicine · doi:10.1097/md.0000000000035110 · Cited by 3 · see citing works
“[19] In clinical care practice, doctors could guide younger patients to translate their potential motivation into practical action to enhance their confidence in the treatment and reduce the level of FCR. Consistent with a previous study, [20] our results showed a higher FCR level associated with…”
ResultEisenberg, E., & Josselin, D. (2024) · Qualitative Health Research · doi:10.1177/10497323231224777 · Cited by 3 · see citing works
Mobile Applications to Promote Mental Health among Breast Cancer Patients: A Rapid Review
BorjAlilu, S., Karbakhsh, M., Lotfi, M., Haghshenas, E., & Kaviani, A. (2023) · Archives of Breast Cancer · doi:10.32768/abc.2023102103-113 · Cited by 3 · see citing works
Zari Moin, Z., Abolmaali Alhosseini, K., & Sirafi, M. R. (2022) · Archives of Breast Cancer · doi:10.32768/abc.202294497-504 · Cited by 3 · see citing works
“It applies acceptance and commitmentbased strategies together with behavior change and commitment strategies to enhance psychological flexibility.(10) ACT is a structured program associated with cognitive-behavioral treatment strategies; i.”
BackgroundXie, X., Ren, Y., Yao, J., Fei, Y., Liu, F., Tong, Q., Huang, J., Kou, M., Jin, C., Yang, W., et al. (2025) · International Journal of Nursing Sciences · doi:10.1016/j.ijnss.2025.06.003 · Cited by 5 · see citing works
Benedict, C., Nouriani, B., Neri, E., Miller, K., Kurian, A. W., Gross, J. J., & Spiegel, D. (2024) · Cancer Medicine · doi:10.1002/cam4.70357 · Cited by 4 · see citing works
Self-citationXu, K., Zhang, X. Y., Yan, J. H., Guo, X., Zhu, S., Zhang, H., & Sun, Y. Y. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-069121 · Cited by 2 · see citing works
Cohee, A. A., Krueger, E., Vachon, E. A., Cottingham, A. H., Stutz, P. V., Alwine, J. S., & Johns, S. A. (2021) · Journal of Psychosocial Oncology Research and Practice · doi:10.1097/or9.0000000000000042 · Cited by 2 · see citing works
Self-citationZhang, B., Deng, H., Ren, J., Legrand, F. D., Ahmad Yusof, H., Zhang, R., & Leong Bin Abdullah, M. F. I. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-080315 · Cited by 2 · see citing works
“24 25 ACT targets self-defeating thoughts and emotions (internal barriers) by focusing onto working towards personal values, which foster development and maintenance of self-management of positive health behaviours.”
Background
- Authors
- Johns, S. A., Stutz, P. V., Talib, T. L., Cohee, A. A., Beck‐Coon, K. A., Brown, L. F., Wilhelm, L. R., Monahan, P. O., LaPradd, M. L., Champion, V. L., Miller, K. D., & Giesler, R. B.
- Affiliations
- Regenstrief Institute (US)
- Indiana University Indianapolis (US)
- West Virginia University (US)
- Butler University (US)
- Corresponding author
- Johns, Shelley A.
- ORCID
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2019-09-20
- Volume
- 126
- Issue
- 1
- Pages
- 211-218
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- PMC
- PMC6906228
- OpenAlex
- W2974123878
- Cited by
- 141
- References
- 43
- Citations by year
- 2026: 18 · 2025: 20 · 2024: 19 · 2023: 25 · 2022: 29 · 2021: 21 · 2020: 8 · 2019: 1
- FWCI
- 6.15
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- IUScholarWorks (Indiana University) (submittedVersion)
- Funders
- Indiana University Health (0952)
- National Cancer Institute (K05CA175048)
- Walther Cancer Foundation (0175.01)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
- Keywords
- acceptance and commitment therapy, fear of cancer recurrence, breast cancer survivors, group therapy, survivorship education, psychological flexibility, avoidance coping, anxiety, depression, post-traumatic stress, quality of life, psychological distress, feasibility
- MeSH terms
- Cancer Survivors, Involuntary Commitment, Adult, Aged, Anxiety, Breast, Breast Neoplasms, Depression, Fear, Female, Humans, Middle Aged, Neoplasm Recurrence, Local, Neoplasm Staging, Phobic Disorders, Quality of Life, Stress Disorders, Post-Traumatic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read under definition version 3 (extract-v3) on 2026-09-28.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-09-28.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review